Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | 401.85% |
| Total Revenue | -- | -- | -- | -- | 401.85% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 401.85% |
| SG&A Expenses | -14.29% | -14.29% | -2.67% | -2.67% | 1.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.29% | -14.29% | -2.67% | -2.67% | 1.82% |
| Operating Income | -2,566.67% | -2,566.67% | 2.67% | 2.67% | 95.93% |
| Income Before Tax | 102.56% | 102.56% | 117.23% | 117.23% | -1,381.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 102.56% | 102.56% | 117.23% | 117.23% | -1,381.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.56% | 102.56% | 117.23% | 117.23% | -1,381.94% |
| EBIT | -2,566.67% | -2,566.67% | 2.67% | 2.67% | 95.93% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 102.80% | 102.80% | -424.00% | -424.00% | -1,411.54% |
| Normalized Basic EPS | 0.00% | 0.00% | -- | -- | 12.50% |
| EPS Diluted | 102.80% | 102.80% | -424.00% | -424.00% | -1,411.54% |
| Normalized Diluted EPS | 0.00% | 0.00% | -- | -- | 12.50% |
| Average Basic Shares Outstanding | -6.57% | -6.57% | -- | -- | -2.76% |
| Average Diluted Shares Outstanding | -6.57% | -6.57% | 15.14% | 15.14% | -2.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |